Literature DB >> 31596195

Enhanced GII.4 human norovirus infection in gnotobiotic pigs transplanted with a human gut microbiota.

Shaohua Lei1,2, Erica L Twitchell2, Ashwin K Ramesh2, Tammy Bui2, Elizabeth Majette2, Christine M Tin2, Roger Avery2, Gustavo Arango-Argoty3, Liqing Zhang3, Sylvia Becker-Dreps4, M Andrea Azcarate-Peril5, Xi Jiang6, Lijuan Yuan2.   

Abstract

The role of commensal microbiota in enteric viral infections has been explored extensively, but the interaction between human gut microbiota (HGM) and human norovirus (HuNoV) is poorly understood. In this study, we established an HGM-Transplanted gnotobiotic (Gn) pig model of HuNoV infection and disease, using an infant stool as HGM transplant and a HuNoV GII.4/2006b strain for virus inoculation. Compared to germ-free Gn pigs, HuNoV inoculation in HGMT Gn pigs resulted in increased HuNoV shedding, characterized by significantly higher shedding titres on post inoculation day (PID) 3, 4, 6, 8 and 9, and significantly longer mean duration of virus shedding. In addition, virus titres were significantly higher in duodenum and distal ileum of HGMT Gn pigs on PID10, while comparable and transient HuNoV viremia was detected in both groups. 16S rRNA gene sequencing demonstrated that HuNoV infection dramatically altered intestinal microbiota in HGMT Gn pigs at the phylum (Proteobacteria, Firmicutes and Bacteroidetes) and genus (Enterococcus, Bifidobacterium, Clostridium, Ruminococcus, Anaerococcus, Bacteroides and Lactobacillus) levels. In summary, enhanced GII.4 HuNoV infection was observed in the presence of HGM, and host microbiota was susceptible to disruption upon HuNoV infection.

Entities:  

Keywords:  Human norovirus; diarrhea; faecal microbiota transplantation; gnotobiotic pig; human gut microbiota

Year:  2019        PMID: 31596195      PMCID: PMC7137776          DOI: 10.1099/jgv.0.001336

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  52 in total

1.  Tropism for tuft cells determines immune promotion of norovirus pathogenesis.

Authors:  Craig B Wilen; Sanghyun Lee; Leon L Hsieh; Robert C Orchard; Chandni Desai; Barry L Hykes; Michael R McAllaster; Dale R Balce; Taylor Feehley; Jonathan R Brestoff; Christina A Hickey; Christine C Yokoyama; Ya-Ting Wang; Donna A MacDuff; Darren Kreamalmayer; Michael R Howitt; Jessica A Neil; Ken Cadwell; Paul M Allen; Scott A Handley; Menno van Lookeren Campagne; Megan T Baldridge; Herbert W Virgin
Journal:  Science       Date:  2018-04-13       Impact factor: 47.728

2.  Molecular characterization of fecal microbiota in patients with viral diarrhea.

Authors:  Chaofeng Ma; Xiaokang Wu; Muhammad Nawaz; Jinsong Li; Pengbo Yu; John E Moore; Jiru Xu
Journal:  Curr Microbiol       Date:  2011-07-08       Impact factor: 2.188

3.  Pathogenesis of a genogroup II human norovirus in gnotobiotic pigs.

Authors:  Sonia Cheetham; Menira Souza; Tea Meulia; Sheila Grimes; Myung Guk Han; Linda J Saif
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

4.  Intranasal P particle vaccine provided partial cross-variant protection against human GII.4 norovirus diarrhea in gnotobiotic pigs.

Authors:  Jacob Kocher; Tammy Bui; Ernawati Giri-Rachman; Ke Wen; Guohua Li; Xingdong Yang; Fangning Liu; Ming Tan; Ming Xia; Weiming Zhong; Xi Jiang; Lijuan Yuan
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

5.  Antibiotic treatment suppresses rotavirus infection and enhances specific humoral immunity.

Authors:  Robin Uchiyama; Benoit Chassaing; Benyue Zhang; Andrew T Gewirtz
Journal:  J Infect Dis       Date:  2014-01-16       Impact factor: 5.226

6.  Intestinal microbiota promote enteric virus replication and systemic pathogenesis.

Authors:  Sharon K Kuss; Gavin T Best; Chris A Etheredge; Andrea J Pruijssers; Johnna M Frierson; Lora V Hooper; Terence S Dermody; Julie K Pfeiffer
Journal:  Science       Date:  2011-10-14       Impact factor: 47.728

7.  QIIME allows analysis of high-throughput community sequencing data.

Authors:  J Gregory Caporaso; Justin Kuczynski; Jesse Stombaugh; Kyle Bittinger; Frederic D Bushman; Elizabeth K Costello; Noah Fierer; Antonio Gonzalez Peña; Julia K Goodrich; Jeffrey I Gordon; Gavin A Huttley; Scott T Kelley; Dan Knights; Jeremy E Koenig; Ruth E Ley; Catherine A Lozupone; Daniel McDonald; Brian D Muegge; Meg Pirrung; Jens Reeder; Joel R Sevinsky; Peter J Turnbaugh; William A Walters; Jeremy Widmann; Tanya Yatsunenko; Jesse Zaneveld; Rob Knight
Journal:  Nat Methods       Date:  2010-04-11       Impact factor: 28.547

8.  Protein deficiency reduces efficacy of oral attenuated human rotavirus vaccine in a human infant fecal microbiota transplanted gnotobiotic pig model.

Authors:  Ayako Miyazaki; Sukumar Kandasamy; Husheem Michael; Stephanie N Langel; Francine C Paim; Juliet Chepngeno; Moyasar A Alhamo; David D Fischer; Huang-Chi Huang; Vishal Srivastava; Dipak Kathayat; Loic Deblais; Gireesh Rajashekara; Linda J Saif; Anastasia N Vlasova
Journal:  Vaccine       Date:  2018-09-12       Impact factor: 3.641

9.  Modeling human enteric dysbiosis and rotavirus immunity in gnotobiotic pigs.

Authors:  Erica L Twitchell; Christine Tin; Ke Wen; Husen Zhang; Sylvia Becker-Dreps; M Andrea Azcarate-Peril; Samuel Vilchez; Guohua Li; Ashwin Ramesh; Mariah Weiss; Shaohua Lei; Tammy Bui; Xingdong Yang; Stacey Schultz-Cherry; Lijuan Yuan
Journal:  Gut Pathog       Date:  2016-11-08       Impact factor: 4.181

10.  Temporal development of the gut microbiome in early childhood from the TEDDY study.

Authors:  Christopher J Stewart; Nadim J Ajami; Jacqueline L O'Brien; Diane S Hutchinson; Daniel P Smith; Matthew C Wong; Matthew C Ross; Richard E Lloyd; HarshaVardhan Doddapaneni; Ginger A Metcalf; Donna Muzny; Richard A Gibbs; Tommi Vatanen; Curtis Huttenhower; Ramnik J Xavier; Marian Rewers; William Hagopian; Jorma Toppari; Anette-G Ziegler; Jin-Xiong She; Beena Akolkar; Ake Lernmark; Heikki Hyoty; Kendra Vehik; Jeffrey P Krischer; Joseph F Petrosino
Journal:  Nature       Date:  2018-10-24       Impact factor: 69.504

View more
  7 in total

Review 1.  Controlled Human Infection Models To Accelerate Vaccine Development.

Authors:  Robert K M Choy; A Louis Bourgeois; Christian F Ockenhouse; Richard I Walker; Rebecca L Sheets; Jorge Flores
Journal:  Clin Microbiol Rev       Date:  2022-07-06       Impact factor: 50.129

Review 2.  Polymicrobial Interactions Operative during Pathogen Transmission.

Authors:  Hannah M Rowe; Jason W Rosch
Journal:  mBio       Date:  2021-05-18       Impact factor: 7.867

3.  Risk Factors and Clinical Profile of Sapovirus-associated Acute Gastroenteritis in Early Childhood: A Nicaraguan Birth Cohort Study.

Authors:  Nadja A Vielot; Fredman González; Yaoska Reyes; Omar Zepeda; Bryan Blette; Margarita Paniagua; Christian Toval-Ruíz; Marta Diez-Valcarce; Michael G Hudgens; Lester Gutiérrez; Patricia Blandón; Roberto Herrera; Edwing Centeno Cuadra; Natalie Bowman; Samuel Vilchez; Jan Vinjé; Sylvia Becker-Dreps; Filemón Bucardo
Journal:  Pediatr Infect Dis J       Date:  2021-03-01       Impact factor: 3.806

Review 4.  Microbiota in viral infection and disease in humans and farm animals.

Authors:  Lijuan Yuan; Casey Hensley; Hassan M Mahsoub; Ashwin K Ramesh; Peng Zhou
Journal:  Prog Mol Biol Transl Sci       Date:  2020-04-24       Impact factor: 3.622

Review 5.  Enteric Viruses and Inflammatory Bowel Disease.

Authors:  Georges Tarris; Alexis de Rougemont; Maëva Charkaoui; Christophe Michiels; Laurent Martin; Gaël Belliot
Journal:  Viruses       Date:  2021-01-13       Impact factor: 5.048

6.  Evaluation of the 50% Infectious Dose of Human Norovirus Cin-2 in Gnotobiotic Pigs: A Comparison of Classical and Contemporary Methods for Endpoint Estimation.

Authors:  Ashwin K Ramesh; Viviana Parreño; Philip J Schmidt; Shaohua Lei; Weiming Zhong; Xi Jiang; Monica B Emelko; Lijuan Yuan
Journal:  Viruses       Date:  2020-08-28       Impact factor: 5.048

Review 7.  The Role of Host Glycobiology and Gut Microbiota in Rotavirus and Norovirus Infection, an Update.

Authors:  Nazaret Peña-Gil; Cristina Santiso-Bellón; Roberto Gozalbo-Rovira; Javier Buesa; Vicente Monedero; Jesús Rodríguez-Díaz
Journal:  Int J Mol Sci       Date:  2021-12-15       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.